Higher pharmaceutical public expenditure after direct price control: improved access or induced demand? The Colombian case

BMC Cost Effectiveness and Resource Allocation
http://resource-allocation.biomedcentral.com/
(Accessed 3 March 2018)

Research
2 March 2018
Higher pharmaceutical public expenditure after direct price control: improved access or induced demand? The Colombian case
Authors: Sergio I. Prada, Victoria E. Soto, Tatiana S. Andia, Claudia P. Vaca, Álvaro A. Morales, Sergio R. Márquez and Alejandro Gaviria